Goncalves Joana

Chief Medical Officer

Goncalves Joana has filed 12 SEC Form 4 filings (63 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Oct 15, 2026.

On the most recent filing, Goncalves Joana is listed as Chief Medical Officer at Oruka Therapeutics, Inc. Inside the rolling window, Goncalves Joana reported no open-market purchases and 11 open-market sales totaling $5.1M in ORKA. The largest disclosed transaction in the window is a sale of 7,000 ORKA shares on Aug 17, 2026, worth $783K.

Companies traded

Other insiders at ORKA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$5.1M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ORKASale$524KOct 15SEC ↗
ORKASale$734KSep 15SEC ↗
ORKASale$783KAug 17SEC ↗
ORKASale$604KJul 15SEC ↗
ORKASale$551KJun 15SEC ↗
ORKASale$433KMay 16SEC ↗
ORKASale$463KApr 15SEC ↗
ORKASale$313KMar 17SEC ↗
ORKASale$227KFeb 17SEC ↗
ORKASale$223KJan 16SEC ↗
ORKASale$214KDec 19SEC ↗
Showing 1–11 of 11
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Goncalves Joana made?

Goncalves Joana has filed 12 SEC Form 4 filings (63 transaction rows) across 1 company since 2025.

Which companies does Goncalves Joana trade?

Goncalves Joana has filed SEC Form 4 disclosures for 1 company, including ORKA.

When was Goncalves Joana's most recent SEC Form 4 filing?

Goncalves Joana's most recent SEC Form 4 filing on Tracefour is dated Oct 15, 2026.

What is Goncalves Joana's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Goncalves Joana is listed as Chief Medical Officer.

What is Goncalves Joana's total buy and sell value in the current window?

Inside the rolling retention window, Goncalves Joana bought $0 and sold $5.1M based on SEC Form 4 filings.

What was Goncalves Joana's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 7,000 ORKA shares on 2026-08-17, worth $783K, per SEC Form 4 filings.